US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Roundhill GLP-1 & Weight Loss ETF

29.60

+0.31121.06%

Post-market: 29.660.0591+0.20%19:30 EDT

Volume:5K

Turnover:139.63K

Market Cap:55.35M

PE:- -

High:29.66

Open:29.08

Low:29.08

Close:29.29

52wk High:37.15

52wk Low:27.34

Shares:1.87M

Float Shares:1.87M

Volume Ratio:0.44

T/O Rate:0.25%

Dividend:0.41

Dividend Rate:1.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll

THOMSON REUTERS

Pfizer Says Litfulo Safety Profile in NSV Consistent with Alopecia Areata

Pfizer Tilrekimig Data Support TSLP Role in Atopic Dermatitis, UBS Says

MT Newswires Live

Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline

Pfizer’s TACTIVE-U Breast Cancer Combo Trial Reaches Key Milestone

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Pfizer Says Phase 3 Trials Show Litfulo Improves Repigmentation in Nonsegmental Vitiligo Patients at Week 52

Pfizer - to Submit Litfulo Phase 3 Data to FDA and Ema

THOMSON REUTERS

Pfizer - Litfulo Safety Profile in Nsv Consistent with Alopecia Areata; no New Safety Signals

THOMSON REUTERS

Pfizer’s Litfulo Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo~

THOMSON REUTERS

Moderately bullish activity in Novo Nordisk with shares up 0.39%

Correction: Top Midday Decliners

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Tilray (TLRY)

Jefferies Adjusts Price Target on Pfizer to $35 From $34, Keeps Buy Rating

MT Newswires Live

Major Drugmakers Turn to China for Licensing Deals

Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals

Jefferies Sticks to Their Buy Rating for Pfizer (PFE)

UBS Sticks to Their Hold Rating for Pfizer (PFE)

Pfizer : Jefferies Raises Target Price to $35 from $34

THOMSON REUTERS

Pfizer Inc. Stock Outperforms Competitors Despite Losses on the Day

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/OZEM/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"OZEM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OZEM\",,,,,undefined,":{"symbol":"OZEM","market":"US","secType":"STK","nameCN":"Roundhill GLP-1 & Weight Loss ETF","latestPrice":29.6009,"timestamp":1791576000000,"preClose":29.2897,"halted":0,"volume":4738,"hourTrading":{"tag":"盘后","latestPrice":29.66,"preClose":29.6009,"latestTime":"19:30 EDT","volume":28,"amount":834.1645,"timestamp":1791588604805,"change":0.0591,"changeRate":0.001997,"amplitude":0},"delay":0,"changeRate":0.010624895441059467,"floatShares":1870002,"shares":1870002,"eps":0,"marketStatus":"Market Closed","change":0.3112,"latestTime":"10-09 16:00:00 EDT","open":29.08,"high":29.66,"low":29.08,"amount":139627.04060799998,"amplitude":0.019802,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":29.2897,"sharesOutstanding":1670000,"nav":29.3,"aum":54791000,"dividendRate":0.013854,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":29.99,"preClose":29.2897,"latestTime":"09:03 EDT","volume":98,"amount":2957.4298879999997,"timestamp":1791551018519,"change":0.7003,"changeRate":0.023909,"amplitude":0.089793},"postHourTrading":{"tag":"盘后","latestPrice":29.66,"preClose":29.6009,"latestTime":"19:30 EDT","volume":28,"amount":834.1645,"timestamp":1791588604805,"change":0.0591,"changeRate":0.001997,"amplitude":0},"volumeRatio":0.44187044434299766,"impliedVol":0.3308,"impliedVolPercentile":0.9402},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OZEM\",,,,,undefined,":{"symbol":"OZEM","floatShares":1870002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.44187044434299766,"shares":1870002,"dividePrice":0.4101,"high":29.66,"amplitude":0.019802,"preClose":29.2897,"low":29.08,"week52Low":27.34,"pbRate":"--","week52High":37.15,"institutionHeld":0,"latestPrice":29.6009,"eps":0,"divideRate":0.013854,"volume":4738,"delay":0,"ttmEps":0,"open":29.08,"prevYearClose":34.1569,"prevWeekClose":29.9329,"prevMonthClose":30.79,"prevQuarterClose":30.79,"fiveDayClose":29.9329,"twentyDayClose":31.1335,"sixtyDayClose":32.8399},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OZEM\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"OZEM","amount":0.409914,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Roundhill GLP-1 & Weight Loss ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2025-12-31"},{"date":"2024-12-30","symbol":"OZEM","amount":0.05307,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"Roundhill GLP-1 & Weight Loss ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OZEM\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-30","recordDate":"2024-12-30","paymentDate":"2024-12-31","value":0.05307,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2025-12-31","value":0.409914,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OZEM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OZEM\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672874637","title":"Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll","url":"https://stock-news.laohu8.com/highlight/detail?id=2672874637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672874637?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:05","pubTimestamp":1790967939,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nTUA8VSLSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1974910355.USD","LU2168564495.EUR","LU2324357040.USD","LU0417517546.SGD","LU0466842654.USD","IE00BN29S564.USD","IYH","LU2089283258.USD","LU2361044865.SGD","LU0203201768.USD","LU2112291526.USD","LU1988902786.USD","IE0001KFT4U8.USD","LU1979441026.SGD","IXJ","LU2264538146.SGD","GDOC","PJP","PPH","LU0106261372.USD","IE00B4JS1V06.HKD","LU0640476718.USD","LU0471298694.HKD","LU1712237335.SGD","LU1064131342.USD","LU2237443978.SGD","FTXH","LU0889565916.HKD","VHT","MEDI","SG9999015986.USD","SGXZ99366536.SGD","LU0823434740.USD","LU1629891620.HKD","LU1023059063.AUD","LU0122379950.USD","LU1917777945.USD","LU2237438978.USD","LU1069344957.HKD","LU2108987350.USD","LU1366192091.USD","LU2360106947.USD","LU2756315664.SGD","LU0353189763.USD","LU1127390331.HKD","LLYX","LU0353189680.USD","LU0114720955.EUR","LU1280957306.USD","LU2023251221.USD","GB00BDT5M118.USD","LU0094547139.USD","IE00B7KXQ091.USD","IE00BWXC8680.SGD","LU1804176565.USD","LU0820561818.USD","BK4581","LU1720051017.SGD","IE00BJJMRY28.SGD","LU2063271972.USD","LU0109391861.USD","FHLC","LU0174119429.USD","LU0385154629.USD","IE00BK4W5M84.HKD","BK4599","LU2237443622.USD","SG9999018865.SGD","LU0198837287.USD","LU2168563687.JPY","SGXZ31699556.SGD","LU0109394709.USD","LU1868837300.USD","LU2028103732.USD","LU2089284900.SGD","SG9999015952.SGD","LU1868836757.USD","BK4585","LU1989771016.USD","IE00B1XK9C88.USD","LU0210536198.USD","LU2089984988.USD","LU2552382215.SGD","IE00BKDWB100.SGD","LU0354030438.USD","IE00BKPKM429.USD","LU2552382058.USD","RXL","LU2491050154.USD","CURE","LU0320765992.SGD","LU2237443895.HKD","SGXZ81514606.USD","LU2750360997.AUD","IE00BJLML261.HKD","LU2462591350.SGD","LU0354030511.USD","IE00BFSS8Q28.SGD","IE0002141913.USD","LU2211815571.USD","BK4007","LU2168564065.EUR","BK4534","HRTS","LU2023250504.SGD","LU0964807845.USD","SG9999014906.USD","LU2462157665.USD","LU0158827781.USD","ELIS","LU0097036916.USD","LU1035775433.USD","SG9999014880.SGD","LU2111349929.HKD","LU1551013342.USD","LU1814569148.SGD","LU2552382132.HKD","LU2357305700.SGD","LU2236285917.USD","LU2750360641.GBP","SG9999015978.USD","LU2491050071.SGD","LU2756315318.SGD","MHIP","LU2271345857.HKD","LU2471134952.CNY","LU1057294990.SGD","LU2168564149.EUR","MEDX","LU0158827948.USD","THNR","IE0005OL40V9.USD","LU2602419157.SGD","LU0787776722.HKD","IE00B4R5TH58.HKD","LU0820561909.HKD","LU0256863902.USD","LU0882574055.USD","LU0345770993.USD","LU1093756325.SGD","ILDR","CANC","IE00B775H168.HKD","LU1323610961.USD","LU2361045086.USD","LU1061106388.HKD","LU2361044949.HKD","LU1551013425.SGD","LU1720051108.HKD","LU2168564222.USD","LU0823434583.USD","IE00BJJMRX11.SGD","LU2471134796.USD","BK4533","IE0009355771.USD","LU0316494557.USD","LU0943347566.SGD","LU2237443465.HKD","SG9999014914.USD","LU0432979614.USD","LU1868836914.USD","LU2456880835.USD","SG9999018857.SGD","TMED","LU1983299246.USD","LU1232071149.USD","XLV","LU2237443382.USD","LU0320765059.SGD","BK4516","LU2746668974.SGD","LU2896262040.SGD","LU2491049909.HKD","IHE","LU2746668461.USD","SG9999013999.USD","LU0456855351.SGD","LU1093756168.USD","LU0256863811.USD","IE00B1BXHZ80.USD","LU2106854487.HKD","LU0238689110.USD","LU1868837136.USD","LU1868836591.USD","LU2265009873.SGD","OZEM","LU1548497426.USD","LU0266013472.USD","LLII","IE0004445239.USD","IE00BK4W5L77.USD","BK4588","LU0006306889.USD","LU0820562030.AUD","LU2023250330.USD","LU0345770308.USD","JDOC","LU0203202063.USD","LU2237443549.SGD","IE00BFSS7M15.SGD","IE00B2B36J28.USD","TRUH","WDNA","SG9999001176.SGD","LU0689472784.USD","SG9999017495.SGD","LU0683600562.USD","LU0823416689.USD","LU0133085943.USD","LU2471134523.USD","SG9999015945.SGD","LU0096364046.USD","LU0323591593.USD","LU0471298777.SGD","LU2461242641.AUD","IE00BJT1NW94.SGD","LU1291159041.SGD","SG9999014898.SGD","LU2417539215.USD","LU0708995401.HKD","LLYZ","LLY","LU0079474960.USD","LU2087625088.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0672654240.SGD","LU1267930730.SGD","SG9999001176.USD","LU2213496289.HKD","LU0061475181.USD","LU0786609619.USD","LU0289739699.SGD","ELIL","LU0882574139.USD","LU2471134879.HKD","LU1691799644.USD","LU1623119135.USD","LU0058720904.USD","LU0225283273.USD","IE0004445015.USD","AGNG","SGXZ51526630.SGD","IE00BJJMRZ35.SGD","LU1145028129.USD","SGXZ57979304.SGD","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672453137","title":"Pfizer Says Litfulo Safety Profile in NSV Consistent with Alopecia Areata","url":"https://stock-news.laohu8.com/highlight/detail?id=2672453137","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672453137?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:24","pubTimestamp":1790961886,"startTime":"0","endTime":"0","summary":"BRIEF-Pfizer Says Litfulo Safety Profile In NSV Consistent With Alopecia AreataOct 2 (Reuters)-Pfizer Inc.PFE.N:PFIZER’S LITFULO SIGNIFICANTLY IMPROVED FACIAL AND TOTAL BODY REPIGMENTATION IN PATIENTS","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU0225771236.USD","LU0225284248.USD","BK4592","LU0289739699.SGD","SG9999001176.SGD","LU0868494617.USD","SG9999002232.USD","LU1894683348.USD","BK4588","BK4568","LU0456855351.SGD","LU1023059063.AUD","IE0002270589.USD","LU0234572021.USD","BK4585","LU0122379950.USD","LU1066053197.SGD","PFE","LU0985481810.HKD","LU1883839398.USD","SG9999003800.SGD","LU0306806265.USD","IE00BBT3K403.USD","BK4550","SG9999001176.USD","SG9999013999.USD","BK4533","LU1894683264.USD","IE00B3T34201.USD","LU0170899867.USD","LU1066051498.USD","LU0321505439.SGD","IE00BLSP4452.SGD","LU1057294990.SGD","IE00BLSP4239.USD","BK4581","LU0306807586.USD","IE000M9KFDE8.USD","LU0058720904.USD","SG9999011175.SGD","BK4007","LU0321505868.SGD","SGXZ57979304.SGD","BK4534","LU2596442595.SGD","OZEM","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672235743","title":"Pfizer Tilrekimig Data Support TSLP Role in Atopic Dermatitis, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672235743","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672235743?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:54","pubTimestamp":1790960085,"startTime":"0","endTime":"0","summary":"Pfizer's  phase II data for its monthly IL-4, IL-13 and TSLP drug tilrekimig showed placebo-adjusted EASI-75 responses of about 40% to 50%, supporting the potential benefit of adding TSLP inhibition in atopic dermatitis, UBS Securities said.The investment firm said in a note Thursday that the results appear competitive with next-generation agents and above Dupixent on a placebo-adjusted EASI-75 basis.The firm also noted low rates of eye-related adverse events and consistent trends in itch reduction, while the study's placebo response was lower than in some comparable trials.Pfizer has started phase III studies of tilrekimig in asthma and atopic dermatitis, including a head-to-head study against Dupixent. The program could become a meaningful commercial player if successful, according to the note.UBS has a neutral rating on the company's stock, with a $27 price target.Shares of Pfizer were down 2% in Friday afternoon trading.Price: 27.55, Change: -0.57, Percent Change: -2.04","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999001176.SGD","BK4007","IE00B19Z3581.USD","LU1023059063.AUD","SG9999011175.SGD","LU0321505439.SGD","BK4592","SG9999003800.SGD","LU2596442595.SGD","BK4585","LU1057294990.SGD","LU0058720904.USD","OZEM","LU0225284248.USD","SGXZ57979304.SGD","BK4550","IE000M9KFDE8.USD","LU1894683348.USD","BK4581","SG9999001176.USD","SG9999002224.SGD","IE00BLSP4452.SGD","LU1894683264.USD","BK4533","SG9999013999.USD","BK4568","LU1066051498.USD","LU1066053197.SGD","IE00B19Z3B42.SGD","IE00B3T34201.USD","LU0170899867.USD","BK4534","SG9999002232.USD","BK4588","IE0002270589.USD","LU0234572021.USD","LU0868494617.USD","LU0306806265.USD","IE00BLSP4239.USD","LU1883839398.USD","LU0306807586.USD","LU0225771236.USD","LU0289739699.SGD","LU0985481810.HKD","LU0321505868.SGD","BK4599","PFE","LU0122379950.USD","LU0456855351.SGD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672743136","title":"Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2672743136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672743136?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:31","pubTimestamp":1790958671,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The study Investigating the Effect of Post-dose Meal Timings and Water Vol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-tests-zenagamtide-dosing-to-sharpen-its-obesity-drug-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-tests-zenagamtide-dosing-to-sharpen-its-obesity-drug-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","LU1093756168.USD","THNR","BK4585","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVOH","OZEM","PPH","BK4532","BK4588","NVOC","LU1093756325.SGD","NVOX","NVO","BK4007","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672156743","title":"Pfizer’s TACTIVE-U Breast Cancer Combo Trial Reaches Key Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2672156743","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672156743?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:30","pubTimestamp":1790958630,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has updated results from its TACTIVE-U Sub-Study C, a Phas...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-tactive-u-breast-cancer-combo-trial-reaches-key-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-tactive-u-breast-cancer-combo-trial-reaches-key-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4592","IE00BLSP4239.USD","SG9999001176.USD","SG9999001176.SGD","BK4585","LU2596442595.SGD","OZEM","LU1023059063.AUD","BK4534","LU0306807586.USD","LU0321505868.SGD","LU1057294990.SGD","IE00B19Z3581.USD","PFE","SG9999002232.USD","LU0225284248.USD","SG9999013999.USD","IE00B19Z3B42.SGD","BK4550","LU0289739699.SGD","BK4007","LU0170899867.USD","LU0306806265.USD","BK4599","BK4568","BK4581","LU1883839398.USD","LU0321505439.SGD","LU0868494617.USD","LU0122379950.USD","LU0058720904.USD","LU0456855351.SGD","LU0234572021.USD","LU0985481810.HKD","SG9999002224.SGD","IE0002270589.USD","LU1066051498.USD","SGXZ57979304.SGD","SG9999003800.SGD","LU0225771236.USD","LU1066053197.SGD","IE00BBT3K403.USD","BK4533","LU1894683264.USD","BK4588","LU1894683348.USD","SG9999011175.SGD","IE000M9KFDE8.USD","IE00B3T34201.USD","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672574802","title":"Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2672574802","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672574802?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:03","pubTimestamp":1790956980,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B shed 0.5% to DKK248.75 Friday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 1.1% to 2,596.93.This was the stock's second consecutive day of losses.The company closed DKK161.20 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 4,305,929, compared to the 50-day average trading volume of 4,898,141.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","PPH","BK4585","LU0154236417.USD","LU1093756168.USD","NVOX","BK4532","LU1093756325.SGD","NVOC","IE00BZ1G4Q59.USD","NVOH","OZEM","THNR","BK4007","NVO","BK4588","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672377748","title":"Pfizer Says Phase 3 Trials Show Litfulo Improves Repigmentation in Nonsegmental Vitiligo Patients at Week 52","url":"https://stock-news.laohu8.com/highlight/detail?id=2672377748","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672377748?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:15","pubTimestamp":1790954142,"startTime":"0","endTime":"0","summary":"Pfizer says Phase 3 trials show LITFULO improves repigmentation in nonsegmental vitiligo patients at Week 52Pfizer presented Phase 3 results showing LITFULO improved facial repigmentation and overall ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL6gVNgg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU1883839398.USD","SGXZ57979304.SGD","SG9999011175.SGD","IE00B19Z3581.USD","LU0456855351.SGD","SG9999013999.USD","LU0122379950.USD","BK4599","LU1894683264.USD","BK4585","LU1066051498.USD","LU0321505868.SGD","LU2596442595.SGD","BK4588","BK4007","LU0321505439.SGD","BK4533","IE00B3T34201.USD","BK4581","IE00BLSP4452.SGD","LU0234572021.USD","BK4592","SG9999001176.SGD","SG9999003800.SGD","LU0868494617.USD","LU0306807586.USD","LU0225771236.USD","LU0306806265.USD","LU0985481810.HKD","BK4568","PFE","BK4534","OZEM","SG9999002232.USD","IE00BLSP4239.USD","LU0170899867.USD","LU1894683348.USD","LU1066053197.SGD","SG9999002224.SGD","BK4550","IE00B19Z3B42.SGD","LU0289739699.SGD","IE00BBT3K403.USD","LU0225284248.USD","LU1023059063.AUD","IE0002270589.USD","SG9999001176.USD","LU0058720904.USD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672748319","title":"Pfizer - to Submit Litfulo Phase 3 Data to FDA and Ema","url":"https://stock-news.laohu8.com/highlight/detail?id=2672748319","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672748319?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:15","pubTimestamp":1790954105,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0321505439.SGD","SG9999001176.USD","OZEM","IE00BLSP4239.USD","LU0225771236.USD","BK4599","LU0321505868.SGD","IE00B19Z3B42.SGD","LU0058720904.USD","LU0289739699.SGD","LU1883839398.USD","LU0306807586.USD","BK4585","BK4581","BK4588","LU1894683264.USD","SG9999002232.USD","SG9999011175.SGD","LU0456855351.SGD","LU1066051498.USD","LU0868494617.USD","SG9999003800.SGD","IE00B3T34201.USD","BK4550","BK4534","SGXZ57979304.SGD","IE00BBT3K403.USD","LU0306806265.USD","PFE","BK4007","IE00BLSP4452.SGD","BK4568","LU1023059063.AUD","IE00B19Z3581.USD","LU2596442595.SGD","LU1894683348.USD","IE0002270589.USD","BK4592","LU0122379950.USD","LU0170899867.USD","LU1066053197.SGD","LU1057294990.SGD","SG9999013999.USD","LU0234572021.USD","IE000M9KFDE8.USD","LU0985481810.HKD","SG9999002224.SGD","SG9999001176.SGD","BK4533","LU0225284248.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672474831","title":"Pfizer - Litfulo Safety Profile in Nsv Consistent with Alopecia Areata; no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672474831","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672474831?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:15","pubTimestamp":1790954105,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4592","BK4588","IE00BLSP4452.SGD","BK4534","BK4550","LU0122379950.USD","LU0456855351.SGD","IE000M9KFDE8.USD","BK4007","SG9999013999.USD","SG9999003800.SGD","SG9999011175.SGD","BK4581","LU1894683264.USD","LU0234572021.USD","LU0985481810.HKD","LU1066051498.USD","SG9999002232.USD","LU0225771236.USD","SGXZ57979304.SGD","BK4599","SG9999002224.SGD","LU0058720904.USD","BK4585","LU1894683348.USD","LU1057294990.SGD","LU1066053197.SGD","LU0868494617.USD","LU0321505439.SGD","LU1883839398.USD","BK4568","OZEM","LU0306806265.USD","IE00BLSP4239.USD","SG9999001176.USD","LU2596442595.SGD","IE0002270589.USD","IE00BBT3K403.USD","LU0306807586.USD","IE00B19Z3581.USD","BK4533","LU0289739699.SGD","LU0321505868.SGD","PFE","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0225284248.USD","SG9999001176.SGD","LU0170899867.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672311748","title":"Pfizer’s Litfulo Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo~","url":"https://stock-news.laohu8.com/highlight/detail?id=2672311748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672311748?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:15","pubTimestamp":1790954105,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001176.SGD","BK4007","IE00B19Z3581.USD","LU1023059063.AUD","SG9999011175.SGD","LU0321505439.SGD","BK4592","SG9999003800.SGD","LU2596442595.SGD","BK4585","LU1057294990.SGD","LU0058720904.USD","OZEM","LU0225284248.USD","SGXZ57979304.SGD","BK4550","IE000M9KFDE8.USD","LU1894683348.USD","BK4581","SG9999001176.USD","SG9999002224.SGD","IE00BLSP4452.SGD","LU1894683264.USD","BK4533","SG9999013999.USD","BK4568","LU1066051498.USD","LU1066053197.SGD","IE00B19Z3B42.SGD","IE00B3T34201.USD","LU0170899867.USD","BK4534","SG9999002232.USD","BK4588","IE0002270589.USD","LU0234572021.USD","LU0868494617.USD","LU0306806265.USD","IE00BLSP4239.USD","LU1883839398.USD","LU0306807586.USD","LU0225771236.USD","LU0289739699.SGD","LU0985481810.HKD","LU0321505868.SGD","BK4599","PFE","LU0122379950.USD","LU0456855351.SGD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672103127","title":"Moderately bullish activity in Novo Nordisk with shares up 0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2672103127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672103127?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:15","pubTimestamp":1790950515,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Novo Nordisk (NVO), with shares up 14c, or 0.39%, near $37.55. Options volume relatively light with 6894 contracts t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-up-0-39-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-up-0-39-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4599","BK4588","LU1093756168.USD","NVOH","OZEM","IE00BZ1G4Q59.USD","THNR","BK4007","LU0154236417.USD","NVO","LU1093756325.SGD","NVOC","NVOX","PPH","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672339714","title":"Correction: Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2672339714","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672339714?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:22","pubTimestamp":1790943727,"startTime":"0","endTime":"0","summary":"Corteva  said Thursday that a federal court denied California's request to temporarily block the planned separation of its seed business into a new publicly traded company, Vylor .In a separate announcement, Vylor said it completed its separation from Corteva and will begin trading as an independent public company on the New York Stock Exchange.Corteva shares slumped 84% as intraday trading volume catapulted to nearly 63.5 million from a daily average of about 4.45 million.Foghorn Therapeutics  and Eli Lilly  have decided not to advance FHD-909  into the clinical development expansion phase after reviewing clinical data from a phase 1 dose escalation trial.Foghorn shares sank 20% as intraday trading volume soared to nearly 11.8 million from a daily average of roughly 380,000.Paramount Skydance  CEO David Ellison has asked CNN CEO Mark Thompson to continue after Paramount completes its acquisition of Warner Bros. Discovery , The Wall Street Journal reported Thursday, citing people famil","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002141913.USD","LU0345780950.USD","LU1057294990.SGD","PBJ","LU0133085943.USD","LU1291159041.SGD","SGXZ51526630.SGD","LU1551013425.SGD","LU0943347566.SGD","ELIS","LU0300736062.USD","LU1983299246.USD","LU2471134879.HKD","LU2168564065.EUR","LU0114720955.EUR","LU0203201768.USD","LU2237443549.SGD","LU0203202063.USD","LU1868836757.USD","LU0256863902.USD","LU2237443978.SGD","SG9999014898.SGD","LU2361044865.SGD","SG9999015952.SGD","LU0320765059.SGD","LU2023250330.USD","LU0238689110.USD","LU2324357040.USD","LU1989771016.USD","LU2237443465.HKD","LU0823434740.USD","OZEM","LU1280957306.USD","SGXZ99366536.SGD","LU0820561818.USD","LU0820561909.HKD","THNR","LU1061106388.HKD","LU2456880835.USD","LU2264538146.SGD","BK4534","LU0266013472.USD","LU0612318385.USD","BK4535","LU0320765992.SGD","SKYD","TMED","LU2552382132.HKD","LU0354030511.USD","LU2461242641.AUD","BK4108","LU0980610538.SGD","IE00BJJMRY28.SGD","LU0471298694.HKD","LU0234572021.USD","WBD","LU0353189763.USD","SG9999015945.SGD","LU0820562030.AUD","SG9999017495.SGD","LU2417539215.USD","SG9999015978.USD","LU0174119429.USD","IE00BWXC8680.SGD","LU1868836591.USD","LU2462591350.SGD","LU0149725797.USD","LU0345781412.USD","SG9999015986.USD","LU1623119135.USD","LU0823416689.USD","SGXZ81514606.USD","LU2552382058.USD","LU2552382215.SGD","LU2023250504.SGD","LU2357305700.SGD","LU0061475181.USD","LU2746668974.SGD","LU2168564222.USD","LU2213496289.HKD","LU0094547139.USD","LU1093756168.USD","LU2106854487.HKD","LU2168564149.EUR","IE00BFSS8Q28.SGD","LLY","MHIP","ELIL","FTAG","KROP","LU2271345857.HKD","LU0683600562.USD","BK4516","LU0006306889.USD","BK4139","FTXH","IE00BFTCPJ56.SGD","LU2237443622.USD","LU0158827781.USD","LU2112291526.USD","LU0708995401.HKD","IE00BJT1NW94.SGD","SG9999002521.SGD","LU0786609619.USD","LU0471298777.SGD","LU0630314457.HKD","LU0823434583.USD","MEDI","LU2089984988.USD","LU1069344957.HKD","JDOC","BK4093","LU2111349929.HKD","LU2361045086.USD","IE00BKDWB100.SGD","LU0654597011.USD","LU1064131342.USD","LU1974910355.USD","LU0130102774.USD","LU1988902786.USD","LU2028103732.USD","LU2746668461.USD","VYLR","IE00BK4W5M84.HKD","LU2023251221.USD","LU1127390331.HKD","LU0289739699.SGD","LU0109394709.USD","IYH","LU0456855351.SGD","LU1093756325.SGD","SGXZ31699556.SGD","LU0345770993.USD","VEGI","SG9999018865.SGD","IE00B4JS1V06.HKD","LU0432979614.USD","CANC","HRTS","PYZ","ILDR","IE00BK4W5L77.USD","LU2237443895.HKD","LU0225283273.USD","LU1979441026.SGD","IE00B1XK9C88.USD","LU1201861249.SGD","XLV","LU2462157665.USD","SG9999014906.USD","RXL","LU0256863811.USD","LU0353189680.USD","LU2471134523.USD","LU0672654240.SGD","BK4125","LU1917777945.USD","PJP","LU2087625088.SGD","LU1145028129.USD","LU2237443382.USD","LU0210536198.USD","LU0385154629.USD","SG9999013999.USD","LU0198837287.USD","LU0612318971.USD","BK4598","LU0417517546.SGD","LU0689472784.USD","LU2491049909.HKD","LU2168564495.EUR","IE00BJLML261.HKD","IE00B1BXHZ80.USD","LU1868837136.USD","LU0787776722.HKD","LU0109391861.USD","LU0964807845.USD","SG9999001176.SGD","LU0466842654.USD","LU0300736492.USD","AGNG","LU2063271972.USD","LU1548497426.USD","LU2750360997.AUD","IE00BN29S564.USD","LU0058720904.USD","LU2211815571.USD","LU1691799644.USD","BK4581","LU1430597077.USD","LLII","LU0316494557.USD","LU1551013342.USD","LU1868837300.USD","LU2468319806.SGD","GB00BDT5M118.USD","LU2108987350.USD","LU2471134796.USD","TRUH","LU0477156953.USD","LU2089283258.USD","IE0009355771.USD","IXJ","LU2237438978.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1804176565.USD","LU0323591593.USD","LU1323610961.USD","CTVA","SG9999014880.SGD","PSKY","LU2168563687.JPY","SGXZ57979304.SGD","LU2089284900.SGD","LU0889565916.HKD","BK4588","LU1267930730.SGD","LU1035775433.USD","LU1712237335.SGD","LU0079474960.USD","IE0001KFT4U8.USD","IE0004445015.USD","LU1720051108.HKD","MEDX","LU0882574055.USD","LU1506573853.SGD","IE00B7KXQ091.USD","LU0097036916.USD","LU2750360641.GBP","LU2756315318.SGD","CURE","SG9999001176.USD","GDOC","LLYX","LU0640476718.USD","LU0345770308.USD","LU1629891620.HKD","LU1720051017.SGD","SG9999014914.USD","LU2236285917.USD","SG9999018857.SGD","FHLC","LU2360106947.USD","BK4007","BK4533","IE00BFSS7M15.SGD","LU0122379950.USD","LU0130517989.USD","FHTX","LU0882574139.USD","LU1023059063.AUD","LU2361044949.HKD","LU2491050071.SGD","LU2896262040.SGD","LU1814569148.SGD","WDNA","IE00BJJMRX11.SGD","LU1868836914.USD","LU0354030438.USD","LLYZ","VHT","IE00B775H168.HKD","LU2471134952.CNY","LU0648001328.SGD","IHE","LU2491050154.USD","LU0096364046.USD","LU1232071149.USD","PPH","LU2602419157.SGD","IE0004445239.USD","LU0158827948.USD","IE00BKPKM429.USD","LU1366192091.USD","LU2211817866.USD","BK4585","BK4599","LU2756315664.SGD","IE00BJJMRZ35.SGD","IE0005OL40V9.USD","LU2265009873.SGD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672118397","title":"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Tilray (TLRY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672118397","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672118397?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:30","pubTimestamp":1790940615,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pfizer (PFE) and Tilray (TLRY). Pfizer (PFE) Scoti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-and-tilray-tlry-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-and-tilray-tlry-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B3T34201.USD","LU0306806265.USD","SG9999013999.USD","BK4592","LU1894683348.USD","LU1066053197.SGD","TLRY","IE0002270589.USD","IE00B19Z3B42.SGD","OZEM","LU2596442595.SGD","LU1894683264.USD","LU1023059063.AUD","IE00BBT3K403.USD","BK4596","IE00BLSP4452.SGD","LU0456855351.SGD","LU1066051498.USD","SG9999002232.USD","BK4007","LU0170899867.USD","LU0321505868.SGD","BK4547","LU1883839398.USD","SG9999001176.SGD","BK4533","LU0321505439.SGD","BK4585","BK4534","LU1057294990.SGD","LU0868494617.USD","SG9999001176.USD","LU0058720904.USD","LU0985481810.HKD","BK4581","BK4599","SG9999002224.SGD","LU0234572021.USD","IE00B19Z3581.USD","PFE","IE00BLSP4239.USD","SG9999011175.SGD","BK4557","LU0122379950.USD","LU0306807586.USD","BK4550","LU0225284248.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK4588","LU0289739699.SGD","LU0225771236.USD","BK4568","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672171692","title":"Jefferies Adjusts Price Target on Pfizer to $35 From $34, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2672171692","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672171692?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:34","pubTimestamp":1790937284,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) has an average rating of hold and mean price target of $28.61, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BBT3K403.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","PFE","BK4599","LU0234572021.USD","SG9999001176.USD","LU0306807586.USD","IE00BLSP4452.SGD","SG9999011175.SGD","BK4550","LU0868494617.USD","IE00BLSP4239.USD","LU1023059063.AUD","LU1894683348.USD","BK4585","LU0170899867.USD","SG9999001176.SGD","IE000M9KFDE8.USD","IE00B3T34201.USD","LU0321505439.SGD","LU1057294990.SGD","OZEM","BK4007","LU2596442595.SGD","SG9999003800.SGD","LU1883839398.USD","BK4568","IE00B19Z3581.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4581","SG9999002232.USD","LU0456855351.SGD","LU0122379950.USD","BK4533","BK4534","BK4588","BK4592","LU0289739699.SGD","IE0002270589.USD","LU0985481810.HKD","LU1066051498.USD","LU0225771236.USD","LU1066053197.SGD","SG9999013999.USD","LU0321505868.SGD","LU1894683264.USD","LU0058720904.USD","LU0225284248.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360032135.SGD","LU1481599808.USD","LU0122379950.USD","LU0234570918.USD","LU1551013425.SGD","LU1066051498.USD","02096","BK0196","LU0354030511.USD","03933","LU0053666078.USD","LU2213496289.HKD","LU2357627491.SGD","LU0149534421.HKD","LU0203201768.USD","LU0234572021.USD","BK4559","LU1267930227.SGD","BK4585","LU1989772923.USD","LU1655091616.SGD","SG9999018865.SGD","LU2324357040.USD","LU2114397693.USD","LU1116320901.HKD","SG9999003800.SGD","LU0708995401.HKD","LU1923622614.USD","IE00B1XK9C88.USD","LU0109981661.USD","LU1868836757.USD","LU1146622755.USD","PPH","SG9999004220.SGD","LU0496365809.HKD","LU0965509010.AUD","LU1261432733.SGD","LU2491050071.SGD","LU1894683348.USD","LU1078025761.USD","LU0795875086.SGD","LU2399975544.HKD","LU0882574055.USD","LU1226287792.SGD","BK4566","LU2495084118.USD","LU0976567544.SGD","LU0889566641.SGD","LU1309081286.SGD","LU2580892862.HKD","LU1267930573.SGD","LU1781817850.SGD","LU1291159041.SGD","LU0315179316.USD","LU0575583348.USD","LU0109394709.USD","PFE","LU1064927863.SGD","IE00BBT3K403.USD","LU1670628061.USD","TRUH","LU0634319403.HKD","LU0882574139.USD","LU1019634622.SGD","LU1202635105.USD","LU0133085943.USD","LU1934455194.USD","LU1170363599.USD","LU1941712264.USD","LU0960981461.USD","KURE","IE00BKDWB100.SGD","LU1003076772.USD","LU2039709279.SGD","LU0477156953.USD","IE000WAW04H5.SGD","LU0348827113.USD","LU0130102774.USD","LU0310800379.SGD","IE00BDGV0183.EUR","LU2097828805.USD","IE00BFTCPJ56.SGD","LU0823434740.USD","LU2125909593.SGD","LU1969619763.USD","LU1127390331.HKD","LU1064130708.USD","LU2089984988.USD","LU0868494617.USD","LU2129689431.USD","09995","LU0963555726.SGD","LU1496350171.SGD","SG9999001440.SGD","LU1066051811.HKD","LU2750360997.AUD","LU0502904849.HKD","GLAM","IE00B4JS1V06.HKD","LU2552382132.HKD","LU2347655156.SGD","LU0553294199.USD","LU0106261372.USD","LU1400636657.SGD","LU1712237335.SGD","LU2539964713.USD","LU0395794307.EUR","LU1548497426.USD","LU0823399737.USD","ILDR","LU0079474960.USD","LU2362540622.SGD","LU2491049909.HKD","LU0969580561.USD","LU2023251221.USD","LU2111349929.HKD","THNR","BK4532","IE00BN29S564.USD","LU1226287529.USD","IE0002270589.USD","LU0889565080.SGD","LU1064131342.USD","LU2063271972.USD","LU2646069778.SGD","BK1589","LU2293690082.USD","IE00B3T34201.USD","LU2108987350.USD","IE00BFXG1179.USD","IXJ","IE000SO60NU8.SGD","LU0203347892.USD","BK0012","SMMT","01276","LU0326950275.SGD","LU0971552830.HKD","LU2896262040.SGD","BK4548","LU1098665638.USD","LU2125154778.USD","LU1093756325.SGD","LU1228905037.USD","LU0128525929.USD","CURE","LU1037948541.HKD","LU0784383803.USD","LU0114720955.EUR","MRK","LU0672654240.SGD","LU0949170772.SGD","LU0868494708.USD","LU1236620834.HKD","LU2279689827.SGD","LU2289578879.USD","LU2168563687.JPY","01530","IE00BN8TJ469.HKD","LU1496350502.SGD","IE000M9KFDE8.USD","LU0130517989.USD","LU1328277881.USD","IE00BLSP4239.USD","LU0171276677.USD","IE00BJJMRZ35.SGD","LU1046248800.SGD","LU0256863811.USD","IE0008368742.USD","LU0708994859.HKD","LU2129689514.USD","LU0323591593.USD","LU2242646821.SGD","LU0689472784.USD","LU0965509101.SGD","BK4535","LU0077335932.USD","LU1019632923.USD","LU0561508036.HKD","LU2293690249.USD","BK1191","LU0098860793.USD","LU1580142542.USD","LU1997244956.HKD","IBBQ","LU2264538146.SGD","LU2242644610.SGD","LU0210536198.USD","LU0289739699.SGD","LU0109391861.USD","LU0949170426.SGD","SGXZ99366536.SGD","LU1831875114.USD","LU0057025933.USD","MEDX","LU0306807586.USD","LU1323610961.USD","LU1941712348.USD","LU0985320562.USD","LU1015430645.USD","LU0096364046.USD","LU1629891620.HKD","LU0557290698.USD","LU0820561818.USD","LU2125909247.SGD","LU0545562505.USD","IE00BWXC8680.SGD","LU2265009873.SGD","LU0320765992.SGD","LU1255011170.USD","IE00B031HY20.USD","LU2476274308.USD","LU0417516571.SGD","LU0889565916.HKD","LU2462591350.SGD","LU2347655073.USD","SG9999015986.USD","LU2462157665.USD","LU0061475181.USD","LU0971552673.USD","MHIP","LU0072461881.USD","IE00B3PB1722.GBP","HRTS","LU1732800096.USD","LU0140636845.USD","BMED","LU2237443549.SGD","LU2328871848.SGD","XLV","LU2491050154.USD","LU2468319806.SGD","600276","LU0471298777.SGD","LU0211331839.USD","LU0390134368.USD","LU0348784397.USD","LU0463099449.HKD","LU0348766576.USD","LU0965509283.SGD","SG9999014898.SGD","LU2237443895.HKD","LU1153584641.USD","LU0316494557.USD","LU0354030438.USD","LU1035773651.USD","LU1074936037.SGD","IE000F7OJYX1.SGD","NVO","03165","BNTX","LU2133065610.SGD","WDNA","LU0972486137.USD","LU0011850046.USD","LU2242652126.USD","LU0640476718.USD","GDOC","LU2237443382.USD","SG9999014914.USD","LU0640478417.SGD","LU1979441026.SGD","LLYX","LU1003077747.HKD","IBB","LU2361044949.HKD","LU0320765646.SGD","IE0034235071.USD","LU2168564222.USD","BK0060","LLYZ","LU2596442595.SGD","LU2129689605.HKD","LU0124676726.USD","IE00BVYPNV92.GBP","LU2097828557.USD","LU1720051017.SGD","LU0211327993.USD","LU2471134879.HKD","IE00BGHQF631.EUR","IE00BPRC5H50.USD","BK1161","LU0310800965.SGD","IE00BFSS7M15.SGD","LU2236285917.USD","BK0183","LU1226288170.HKD","LU1273509221.SGD","LU0289961442.SGD","IE0008369823.USD","LU0211328371.USD","LU0067412154.USD","LU0417517546.SGD","SG9999014575.USD","IE00BSNM7G36.USD","LU1400636574.HKD","LU0511384066.AUD","LU2471134796.USD","BK4588","IE0004445239.USD","GSK.UK","BK4550","IE000MB6IJN5.SGD","IE00B775H168.HKD","LU0244354667.USD","LU0980610538.SGD","LU0265550946.USD","LU2087625088.SGD","LU1720050803.USD","LU2360106947.USD","IE00BZ1G4Q59.USD","BK0239","LU1813983027.USD","LU0417516902.SGD","LU1623119135.USD","LU0266013472.USD","LU0047473722.SGD","LU0499090636.EUR","LU1894683264.USD","LU0029864427.USD","LU1201861249.SGD","IE0004445015.USD","IE00BZ08YS42.EUR","SG9999011175.SGD","LU0265550359.USD","BK4592","SG9999018857.SGD","LU2237443465.HKD","LU2168564065.EUR","IE0001KFT4U8.USD","LU1032466523.USD","LU1188198961.HKD","LU0820561909.HKD","LU0455707207.USD","LLII","LU1064131003.USD","LU1670711040.USD","LU2097828474.EUR","LU1226288253.USD","LU2028103732.USD","LU2580892789.USD","LU0310799852.SGD","LU1670710661.SGD","LU2211815571.USD","LU0289739343.SGD","LU0786609619.USD","SG9999017495.SGD","LU1880407132.USD","LU0964807845.USD","SG9999001176.USD","IE00BJJMRX11.SGD","LU1152091754.HKD","LU1196032939.SGD","LU0943347566.SGD","IE00BWDBJ516.SGD","LU0321505439.SGD","LU0920783379.SGD","IE0000B7K699.USD","LU0957799991.USD","LU0965508806.USD","LU1116320737.USD","LU1119994496.HKD","LU0912757837.SGD","IE00BJLML261.HKD","LU2087621335.USD","LU1718418525.SGD","LU1934455277.USD","SG9999014880.SGD","LU2433249047.HKD","LU2168564495.EUR","LU1302929846.USD","LU2746668974.SGD","TMED","LU0726765562.USD","LU1162221912.USD","LU1093756168.USD","LU0069063385.USD","LU0320765489.SGD","IYH","LU1035775433.USD","LU1267930813.SGD","LU1691799644.USD","LU0784384876.USD","LU1400636491.USD","LU1732799900.SGD","LU1280957306.USD","LU0070302665.USD","MEDI","LU0540923850.HKD","LU1355424745.HKD","LU0203345920.USD","LU1997245177.USD","BK4534","LU2237443622.USD","LU1863844665.USD","SGXZ57979304.SGD","LU0094547139.USD","LU0985481810.HKD","LU0861579265.USD","IE00B19Z3B42.SGD","LU1983299246.USD","LU1084165304.USD","LU0405327148.USD","SG9999001176.SGD","LU0225284248.USD","LU1699723380.USD","LU1934455863.HKD","SGXZ51526630.SGD","TBXU","SG9999002232.USD","IE000BZT7R73.USD","LU1366192091.USD","LU0942090050.USD","LU1807302812.USD","ABBV","AZN.UK","01093","LU0417516738.SGD","LU0857590862.USD","LU1551013342.USD","LU0345770308.USD","LU1244550494.USD","LU2750360641.GBP","LU2361045086.USD","IE0005OL40V9.USD","LU1585245621.USD","LU1839511570.USD","LU0256863902.USD","LU0320765059.SGD","LU1066051225.USD","SG9999014542.SGD","LU0306806265.USD","LU2362541513.USD","IE00BKPKM429.USD","IE00B42XCP33.USD","LU2023250330.USD","LU2168564149.EUR","LU0237698245.USD","LU0456855351.SGD","LU0545039389.USD","LU0880133367.SGD","LU0738911758.USD","LU1328615791.USD","LU0162691827.USD","LU1829250122.USD","IE0002141913.USD","LLY","LU2357305700.SGD","LU2471134952.CNY","SG9999015358.SGD","LU2461242641.AUD","RHHBY","LU2756315318.SGD","LU0058720904.USD","LU0345777659.USD","LU1244550221.USD","ELIL","LU0859254822.USD","NVOC","LU0827474353.SGD","LU1046234339.USD","LU1023059063.AUD","BK1521","LU1989772840.SGD","LU0661504455.SGD","SGXZ81514606.USD","SG9999015341.SGD","BK1587","LU0683600562.USD","LU0170899867.USD","LU2091194634.USD","LU0823416689.USD","LU1670756490.USD","IE00B1BXHZ80.USD","LU0128525689.USD","LU1868837300.USD","SG9999014906.USD","LU0607220059.USD","LU0072913022.USD","LU0006306889.USD","NVOH","IE00BQJZX424.USD","LU0795875169.SGD","LU1035777561.USD","IE00B3M56506.USD","IE00BK4W5L77.USD","LU2271345857.HKD","LU2456880835.USD","LU3187612489.SGD","SG9999014567.USD","LU0225771236.USD","LU1804176565.USD","LU0198837287.USD","IE00B5MMRT66.SGD","SGXZ31699556.SGD","LU1868836914.USD","LU1232071149.USD","LU1037948897.HKD","LU1670627923.USD","LU1267930730.SGD","LU1993786604.SGD","LU0174119429.USD","LU0648001328.SGD","LU2097828714.EUR","LU1720051108.HKD","LU2097828631.EUR","LU1153585028.USD","NVS","LU2476274720.SGD","BK4599","BBH","IHE","LU0689626769.HKD","IE00B7KXQ091.USD","SG9999015945.SGD","LU0526926950.USD","SG9999013999.USD","LU2417539215.USD","LU0353189763.USD","LU1883839398.USD","BK1574","LU1226287875.USD","LU0472753341.HKD","IE00BFSS8Q28.SGD","LU0787776722.HKD","00013","LU2148510915.USD","IE0034235188.USD","LU1571399168.USD","LU1961090484.USD","LU2023250843.SGD","BK1583","HK0000165453.HKD","LU0405327494.USD","LU0471298694.HKD","LU0432979614.USD","BMY","LU1868836591.USD","688331","JDOC","RXL","NVOX","LU1051770623.HKD","LU1061106388.HKD","LU1670710588.SGD","IE00BKPKM643.USD","IE00B4R5TH58.HKD","LU0997586515.USD","LU1244550577.SGD","LU0321505868.SGD","LU1974910355.USD","01801","IE00BVYPNW00.USD","LU0203202063.USD","IE00BJT1NW94.SGD","IE00BJJMRY28.SGD","BK0188","BK4581","BK4516","LU2361044865.SGD","688506","BK0028","LU0345777147.USD","LU1951186391.HKD","LU2089283258.USD","LU0466842654.USD","PJP","LU1152091168.USD","LU2106854487.HKD","LU2471134523.USD","IE00BK4W5M84.HKD","09926","LU0171293334.USD","LU2488822045.USD","IE00BZ08YR35.GBP","LU0314109678.HKD","LU1066053197.SGD","LU1989771016.USD","SG9999015978.USD","LU2552382215.SGD","LU1880407215.USD","LU1481600234.SGD","LU0047473722.EUR","PAWZ","LU2746668461.USD","BK1515","IE00B2B36J28.USD","LU0987226296.USD","LU1057294990.SGD","LU0348783233.USD","LU0385154629.USD","LU1069347547.HKD","LU0348825331.USD","LU2756315664.SGD","LU1487256676.USD","BK4007","LU0501845795.SGD","LU0784385840.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","IE00BLSP4452.SGD","LU0097036916.USD","BK1588","FTXH","LU0225283273.USD","LU1814569148.SGD","LU2552382058.USD","LU0820562030.AUD","LU2237443978.SGD","SG9999015952.SGD","BK4578","LU0161305163.EUR","LU0211326839.USD","LU2112291526.USD","LU0920840948.USD","SG9999014559.SGD","CANC","HCM","LU0964806797.USD","LU0887340254.USD","LU2237438978.USD","IE00BKVL7J92.USD","LU1104425308.USD","LU0052756011.USD","LU1794554557.SGD","LU2125154935.USD","LU1988902786.USD","IE00B19Z3581.USD","LU0345770993.USD","LU1645745479.HKD","LU1820825898.SGD","VHT","LU0267386448.USD","LU0208291251.USD","BK4139","LU1929549753.HKD","LU1670711123.USD","IE0009355771.USD","LU0158827948.USD","GB00BDT5M118.USD","LU0348767384.USD","LU2362541273.HKD","LU0158827781.USD","LU1960683339.HKD","OZEM","LU1430594728.SGD","LU0784385170.HKD","LU0348735423.USD","BK4533","LU0353189680.USD","LU1868837136.USD","LU2778985437.USD","LU0823434583.USD","FHLC","LU0997586432.USD","LU1301847155.USD","03692","ELIS","LU1863844749.USD","LU0757432116.USD","LU1917777945.USD","AGNG","BK1593","BK5011","LU2089284900.SGD","LU1236620750.USD","LU1145028129.USD","LU2355687059.USD","LU1267930490.SGD","SG9999002224.SGD","LU0792757196.USD","LU2602419157.SGD","LU1228905540.USD","LU1069344957.HKD","BK4551","BK4568","LU0238689110.USD","LU1008478684.HKD","REGN","LU0154236417.USD","LU0211326755.USD","LU1997245094.SGD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672137097","title":"Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672137097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672137097?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:35","pubTimestamp":1790933700,"startTime":"0","endTime":"0","summary":"0934 GMT - Sanofi and Regeneron Pharmaceuticals' potential successors to blockbuster medicine Dupixent might lag behind rival drugs Pfizer and AbbVie are developing, Citi analysts say in a research note. The new experimental drugs Sanofi and Regeneron will jointly develop under their alliance focus solely on extending the dosing interval of Dupixent without compromising efficacy or tolerability, but there is no expectation of a superior performance, Citi says. This suggests those medicines might struggle to compete with Pfizer's tilrekimig and AbbVie's zumilokibart, both of which have shown potential for better efficacy in midstage trials, according to Citi. Moreover, it might be challenging for Sanofi and Regeneron to get reimbursement for those drugs from healthcare payers after copycat versions of Dupixent become available, the analysts add. Sanofi shares fall 3.4%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655073.USD","LU2106854487.HKD","IBB","IYH","LU2133065610.SGD","BBH","LU1057294990.SGD","MEDX","SNY","LU0069063385.USD","XLV","LU0158827948.USD","LU1917777945.USD","TRUH","JDOC","IE00BJT1NW94.SGD","AGNG","LU0057025933.USD","LU0795875169.SGD","LU0053666078.USD","LU0203347892.USD","LU0965509283.SGD","TBXU","PJP","VHT","LU0417517546.SGD","LU0098860793.USD","IBBQ","REGN","LU1883839398.USD","FTXH","BK4599","LU2112291526.USD","LU0128525929.USD","FHLC","LU0029864427.USD","LU0211327993.USD","GLAM","LU0949170772.SGD","BK4585","LU1037948541.HKD","LU1244550577.SGD","PFE","PPH","ABBV","IXJ","LU1720051108.HKD","OZEM","RXL","SNYNF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672901197","title":"Jefferies Sticks to Their Buy Rating for Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672901197","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672901197?lang=en_us&edition=fundamental","pubTime":"2026-10-02 15:55","pubTimestamp":1790927713,"startTime":"0","endTime":"0","summary":"Jefferies analyst Akash Tewari maintained a Buy rating on Pfizer today and set a price target of $35.00. According to TipRanks, Tewari is a 5-star ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-their-buy-rating-for-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-their-buy-rating-for-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","IE00BLSP4239.USD","LU0058720904.USD","IE000M9KFDE8.USD","IE00B3T34201.USD","BK4588","SG9999011175.SGD","LU0321505868.SGD","SGXZ57979304.SGD","LU1894683264.USD","LU0170899867.USD","SG9999002232.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","LU0306806265.USD","OZEM","LU1066051498.USD","LU1883839398.USD","SG9999013999.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0306807586.USD","BK4533","LU2596442595.SGD","LU1894683348.USD","SG9999002224.SGD","BK4585","LU1057294990.SGD","LU0122379950.USD","BK4550","LU0234572021.USD","LU0321505439.SGD","BK4568","LU0456855351.SGD","LU0985481810.HKD","SG9999003800.SGD","SG9999001176.USD","BK4007","BK4592","PFE","LU0225771236.USD","LU1066053197.SGD","SG9999001176.SGD","BK4534","IE00BLSP4452.SGD","LU0225284248.USD","LU1023059063.AUD","LU0868494617.USD","BK4581","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672797617","title":"UBS Sticks to Their Hold Rating for Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672797617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672797617?lang=en_us&edition=fundamental","pubTime":"2026-10-02 14:55","pubTimestamp":1790924115,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Yee from UBS maintained a Hold rating on Pfizer, with a price target of $27.00. According to TipRanks, Yee is a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-sticks-to-their-hold-rating-for-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-sticks-to-their-hold-rating-for-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","IE00BLSP4239.USD","LU0058720904.USD","IE000M9KFDE8.USD","IE00B3T34201.USD","BK4588","SG9999011175.SGD","LU0321505868.SGD","SGXZ57979304.SGD","LU1894683264.USD","LU0170899867.USD","SG9999002232.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","LU0306806265.USD","OZEM","LU1066051498.USD","LU1883839398.USD","SG9999013999.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0306807586.USD","BK4533","LU2596442595.SGD","LU1894683348.USD","SG9999002224.SGD","BK4585","LU1057294990.SGD","LU0122379950.USD","BK4550","LU0234572021.USD","LU0321505439.SGD","BK4568","LU0456855351.SGD","LU0985481810.HKD","SG9999003800.SGD","SG9999001176.USD","BK4007","BK4592","PFE","LU0225771236.USD","LU1066053197.SGD","SG9999001176.SGD","BK4534","IE00BLSP4452.SGD","LU0225284248.USD","LU1023059063.AUD","LU0868494617.USD","BK4581","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672479949","title":"Pfizer : Jefferies Raises Target Price to $35 from $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2672479949","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672479949?lang=en_us&edition=fundamental","pubTime":"2026-10-02 11:56","pubTimestamp":1790913413,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45N1GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","LU1066053197.SGD","IE00BBT3K403.USD","BK4581","LU0058720904.USD","BK4550","LU1066051498.USD","LU0234572021.USD","LU0225771236.USD","IE0002270589.USD","LU0321505439.SGD","LU0306806265.USD","LU0289739699.SGD","LU0321505868.SGD","SG9999001176.USD","SGXZ57979304.SGD","BK4568","LU1894683264.USD","LU2596442595.SGD","LU1057294990.SGD","BK4592","BK4534","IE00B19Z3581.USD","LU0306807586.USD","SG9999002224.SGD","IE00B3T34201.USD","LU1883839398.USD","OZEM","IE00B19Z3B42.SGD","SG9999011175.SGD","LU0868494617.USD","LU0456855351.SGD","LU0985481810.HKD","PFE","IE00BLSP4239.USD","SG9999013999.USD","BK4588","IE000M9KFDE8.USD","LU1894683348.USD","BK4599","SG9999003800.SGD","LU0170899867.USD","BK4585","IE00BLSP4452.SGD","LU0225284248.USD","BK4533","BK4007","SG9999001176.SGD","SG9999002232.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672626237","title":"Pfizer Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672626237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672626237?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:36","pubTimestamp":1790886960,"startTime":"0","endTime":"0","summary":"DJ Pfizer Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Pfizer Inc.  slipped 1.40% to $28.12 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's second consecutive day of losses.Pfizer Inc. closed 3.73% short of its 52-week high of $29.21, which the company achieved on September 3rd.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.30% to $258.66, Eli Lilly & Co.  fell 0.62% to $1,149.85, and Abbott Laboratories  fell 2.17% to $96.69.Trading volume  remained 6.5 million below its 50-day average volume of 36.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","IE00B3T34201.USD","LU1066053197.SGD","OZEM","LU1023059063.AUD","IE000M9KFDE8.USD","LU0122379950.USD","IE00BLSP4452.SGD","SGXZ57979304.SGD","LU0306806265.USD","LU0289739699.SGD","LU0321505868.SGD","BK4599","SG9999002224.SGD","SG9999002232.USD","LU2596442595.SGD","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4007","BK4592","LU0225284248.USD","LU0225771236.USD","IE0002270589.USD","LU0306807586.USD","LU0321505439.SGD","LU0868494617.USD","SG9999013999.USD","BK4568","LU0058720904.USD","IE00BBT3K403.USD","LU1057294990.SGD","LU1883839398.USD","BK4550","LU0456855351.SGD","LU0985481810.HKD","BK4588","LU1894683264.USD","LU1066051498.USD","LU1894683348.USD","PFE","SG9999011175.SGD","SG9999003800.SGD","BK4533","IE00B19Z3581.USD","BK4581","BK4585","SG9999001176.USD","LU0234572021.USD","LU0170899867.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":6,"totalSize":233,"code":"91000000","status":"200"}]}}